Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH
|
December 20, 2007
Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies
F Scheiflinger, M Dockal, J Rosing, et al.
Immunotechnology : an International Journal of Immunological Engineering
|
June 1, 1996
pDAP2: a vector for construction of alkaline phosphatase fusion-proteins
R J Kerschbaumer, S Hirschl, C Schwager, et al.
Analytical Biochemistry
|
July 1, 1997
Single-chain Fv fusion proteins suitable as coating and detecting reagents in a double antibody sandwich enzyme-linked immunosorbent assay
R J Kerschbaumer, S Hirschl, A Kaufmann, et al.
Phytopathology
|
October 24, 2008
Fully "Recombinant Enzyme-Linked Immunosorbent Assays" Using Genetically Engineered Single-Chain Antibody Fusion Proteins for Detection of Citrus tristeza virus
E Terrada, R J Kerschbaumer, G Giunta, et al.
Biotechnology and Bioengineering
|
October 24, 2003
Higher expression of Fab antibody fragments in a CHO cell line at reduced temperature
Simone M Schatz, Randolf J Kerschbaumer, Gabriele Gerstenbauer, et al.
Der Radiologe
|
February 17, 2017
[Brain metastasis versus radiation necrosis after head and neck cancer : Brain lesion after head and neck cancer]
B Kofler, J Kerschbaumer, V H Schartinger, et al.
Brain Informatics
|
May 6, 2017
Preoperative prediction of language function by diffusion tensor imaging
C F Freyschlag, J Kerschbaumer, D Pinggera, et al.
The Journal of Biological Chemistry
|
July 22, 2004
An antibody specific for coagulation factor IX enhances the activity of the intrinsic factor X-activating complex
Randolf J Kerschbaumer, Klaudia Riedrich, Martina Kral, et al.
Antibodies (Basel, Switzerland)
|
December 27, 2024
Integrating In Silico and In Vitro Tools for Optimized Antibody Development-Design of Therapeutic Anti-oxMIF Antibodies
Gregor Rossmueller, Irina Mirkina, Michael Thiele, et al.
Molecular Cancer Therapeutics
|
June 4, 2024
Pretargeted radioimmunotherapy with the novel anti-oxMIF/HSG bispecific antibody ON105 results in significant tumor regression in murine models of cancer
Alejandro A Puchol Tarazona, Alexander Schinagl, Irina Mirkina, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Journal of Thrombosis and Haemostasis : JTH
|
December 20, 2007
Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies
F Scheiflinger, M Dockal, J Rosing, et al.
Immunotechnology : an International Journal of Immunological Engineering
|
June 1, 1996
pDAP2: a vector for construction of alkaline phosphatase fusion-proteins
R J Kerschbaumer, S Hirschl, C Schwager, et al.
Analytical Biochemistry
|
July 1, 1997
Single-chain Fv fusion proteins suitable as coating and detecting reagents in a double antibody sandwich enzyme-linked immunosorbent assay
R J Kerschbaumer, S Hirschl, A Kaufmann, et al.
Phytopathology
|
October 24, 2008
Fully "Recombinant Enzyme-Linked Immunosorbent Assays" Using Genetically Engineered Single-Chain Antibody Fusion Proteins for Detection of Citrus tristeza virus
E Terrada, R J Kerschbaumer, G Giunta, et al.
Biotechnology and Bioengineering
|
October 24, 2003
Higher expression of Fab antibody fragments in a CHO cell line at reduced temperature
Simone M Schatz, Randolf J Kerschbaumer, Gabriele Gerstenbauer, et al.
Der Radiologe
|
February 17, 2017
[Brain metastasis versus radiation necrosis after head and neck cancer : Brain lesion after head and neck cancer]
B Kofler, J Kerschbaumer, V H Schartinger, et al.
Brain Informatics
|
May 6, 2017
Preoperative prediction of language function by diffusion tensor imaging
C F Freyschlag, J Kerschbaumer, D Pinggera, et al.
The Journal of Biological Chemistry
|
July 22, 2004
An antibody specific for coagulation factor IX enhances the activity of the intrinsic factor X-activating complex
Randolf J Kerschbaumer, Klaudia Riedrich, Martina Kral, et al.
Antibodies (Basel, Switzerland)
|
December 27, 2024
Integrating In Silico and In Vitro Tools for Optimized Antibody Development-Design of Therapeutic Anti-oxMIF Antibodies
Gregor Rossmueller, Irina Mirkina, Michael Thiele, et al.
Molecular Cancer Therapeutics
|
June 4, 2024
Pretargeted radioimmunotherapy with the novel anti-oxMIF/HSG bispecific antibody ON105 results in significant tumor regression in murine models of cancer
Alejandro A Puchol Tarazona, Alexander Schinagl, Irina Mirkina, et al.
Page
of 3